Indeed, expression and activation of FGFRs were observed in clinical samples of ESFT [18] and, in a recent meta-analysis of mutational data, FGFR3 was found mutated in 50% of ESFT cell lines, being one of the most frequently mutated cancer-associated genes [19]. This evidence concerns the gene FGFR3 and cancer.